
Read More
Stocks to Watch Tomorrow...
Fresh order wins, strategic partnerships and a key European regulatory approval could keep Coal Indi...

Fresh order wins, strategic partnerships and a key European regulatory approval could keep Coal Indi...

Lupin said completion of its proposed acquisition of minority shareholding in Multicare Pharmaceutic...

Lupin received approval from China’s National Medical Products Administration for Oseltamivir Phosph...

Lupin reported Q4FY26 consolidated profit after tax of Rs 1,413.07 crore on revenue from operations ...

Stocks to watch on Monday, April 6, 2026: Lupin, Tata Motors, Maruti Suzuki, and Astra Microwave Pro...

Lupin Ltd completes VISUfarma acquisition, expands its ophthalmology portfolio in Europe, and shows ...

This collaboration significantly strengthens Lupin’s Central Nervous System (CNS) portfolio, providi...

Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics...

This partnership, facilitated through Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA), targets...

The stock is up by 19.33 per cent from its 52-week low and has given multibagger returns of 185 per ...